京尼平诱导猪眼巩膜胶原交联后生物力学性能变化

doi:10.3760/cma.j.issn.1674-845X.2014.05.004

摘要
图/表
参考文献(27)
相关文章 (15)

全文: PDF 1233KB HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

目的观察京尼平诱导胶原交联后猪眼巩膜生物力学的变化，为防治近视的发展探寻潜在的方法。方法实验研究。离体猪眼45只，通过简单随机化方法分为9组，每组5眼。以0.01%、0.10%、1.00%京尼平（w/v）分别处理猪眼巩膜30 min；以核黄素/紫外线A处理的巩膜和未处理的巩膜作为对照组。处理后制作4.0 mm×10.0 mm的巩膜试件。24 h后用INSTRON万能材料机测试巩膜试件生物力学参数，另外还测试1.0%京尼平用药后1、6、12、24、36 h巩膜的生物力学参数；同时观察巩膜试件的颜色变化。应力和弹性模量比较采用方差分析。结果与未治疗组比较，0.01%、0.10%、1.00%京尼平治疗24 h后应力提高了205%～498%，弹性模量增加了109%～467%。0.01%京尼平与核黄素/紫外线A具有相似的应力-应变曲线。而且在1.00%京尼平治疗后24 h内，随时间的延长，巩膜颜色逐渐变蓝；在治疗后1、6、12、24、36 h巩膜极限应力分别较未治疗巩膜增加了53%、146%、164%、223%和175%；弹性模量分别增加了80%、151%、185%、352%和296%。在京尼平治疗后24 h极限应力和弹性模量均达到峰值。结论京尼平可以改善巩膜的生物力学性能，且疗效与其浓度有关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘太祥
	吴君舒
	顾宇伟
	杨斌
	王铮

关键词 ：生物力学, 巩膜, 胶原交联, 京尼平, 近视

Abstract：

Objective Investigate the change of biomechanical properties in porcine sclera treated with genipin and to explore a potential method to prevent the progerssion of myopia. Methods Experimental study. Forty-five porcine cadaver eyes were randomly divided into 9 groups and each group had 5 eyes. Eyes were treated with genipin at concentrations （by w/v） of 0.01%， 0.10%， 1.00% for 30 min. Riboflavin/ultraviolet-A （UVA） treated and untreated samples were used as controls. After treatment， scleral strips of 4.0 mm×10.0 mm were cut. At 24 h after treatment， the stress-strain parameters of the strips were measured using a INSTRON 3343 biomaterial microtester. Additionally， we also performed the stress-strain test at 1， 6， 12， 24 and 36 h after treated with 1.00% genipin. Meanwhile the discoloration of sclera were observed and recorded with slit lamp camera system. The difference of the ultimate stress and modulus between treated and untreated groups were analyzed with One-Way ANOVA in SPSS 17.0. Results Compared with untreated groups， after treatment with genipin for 30 min， the ultimate stress and modulus were increased by 205% to 498% and 109% to 467% respectively. 0.01% genipin for 30min had a similar stress-strain curve with those of eyes treated with riboflavin/UVA. Within 24 h after treating with 1.00% genipin， the sclera exhibited a bluish color which became deeper with time. And at 1， 6， 12， 24 and 36 h after treatment， the ultimate stress were increased by 53%， 146%， 164%， 223% and 175% respectively. The modulus at 8% strain also increased by 80%， 151%， 185%， 352% and 296%. Conclusion Collagen crosslinking treated with genipin could increase the biomechanical strength in porcine sclera. The effect depends on the concentration of genipin.

Key words： Biomechanics Sclera Collagen crosslinking Genipin Myopia

基金资助:

广东省科技计划项目（社会发展）（2007B031002001）

通讯作者: 王铮，Email：wangzhengykzx@163.com

引用本文:

刘太祥,吴君舒,顾宇伟,杨斌,王铮. 京尼平诱导猪眼巩膜胶原交联后生物力学性能变化[J]. 中华眼视光学与视觉科学杂志, 2014, 16(5): 274-278. Liu Taixiang,Wu Junshu,Gu Yuwei,Yang Bin,Wang Zheng. Change of biomechanical properties in porcine sclera treated with genipin. Chinese Journal of Optometry Ophthalmology and Visual Science, 2014, 16(5): 274-278. DOI: 10.3760/cma.j.issn.1674-845X.2014.05.004

链接本文:

https://www.cjoovs.com/CN/10.3760/cma.j.issn.1674-845X.2014.05.004 或 https://www.cjoovs.com/CN/Y2014/V16/I5/274

[1]	Vitale S， Sperduto RD， Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004[J]. Arch ophthalmol，2009，127：1632-1639.
[2]	Sherwin JC， Khawaja AP， Broadway D， et al. Uncorrected refractive error in older British adults： the EPIC-Norfolk Eye Study[J]. Br J Ophthalmol，2012，96：991-996.
[3]	Morgan IG， Ohno-Matsui K， Saw SM. Myopia[J]. Lancet，2012， 379：1739-1748.
[4]	Zadnik K. The Glenn A. Fry Award Lecture （1995）. Myopia development in childhood[J]. Optom Vis Sci，1997，74：603-608.
[5]	Chen MJ， Liu YT， Tsai CC， et al. Relationship between central corneal thickness， refractive error， corneal curvature， anterior chamber depth and axial length[J]. J Chin Med Assoc，2009， 72：133-137.
[6]	Curtin BJ， Teng CC. Scleral changes in pathological myopia[J]. Trans Am Acad Ophthalmol Otolaryngol，1958，62：777-790.
[7]	McBrien NA， Gentle A. Role of the sclera in the development and pathological complications of myopia[J]. Prog Retin Eye Res，2003，22：307-338.
[8]	Rada JA， Shelton S， Norton TT. The sclera and myopia[J]. Exp Eye Res，2006，82：185-200.
[9]	Wollensak G， Spoerl E. Collagen crosslinking of human and porcine sclera[J]. J Cataract Refract Surg，2004，30：689-695.
[10]	Spoerl E， Wollensak G， Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion[J]. Curr Eye Res，2004，29：35-40.
[11]	Sung HW， Huang RN， Huang LL， et al. Feasibility study of a natural crosslinking reagent for biological tissue fixation[J]. J Biomed Mater Res，1998，42：560-567.
[12]	Lai JY， Li YT， Wang TP. In vitro response of retinal pigment epithelial cells exposed to chitosan materials prepared with different cross-linkers[J]. Int J Mol Sci，2010，11：5256-5272.
[13]	Avila MY， Gerena VA， Navia JL. Corneal crosslinking with genipin， comparison with UV-riboflavin in ex-vivo model[J]. Mol Vis，2012，18：1068-1073.
[14]	Sergienko NM， Shargorogska I. The scleral rigidity of eyes with different refractions[J]. Graefes Arch Clin Exp Ophthalmol，2012，250：1009-1012.
[15]	Awetissow ES. The role of the sclera in the pathogenesis of progressive myopia （author′s transl）[J]. Klinische Monatsblatter fur Augenheilkunde，1980，176：777-781.
[16]	Funata M， Tokoro T. Scleral change in experimentally myopic monkeys[J]. Graefes Arch Clin Exp Ophthalmol，1990，228：174-179.
[17]	Bailey AJ. Structure， function and ageing of the collagens of the eye[J]. Eye （Lond），1987，1（Pt 2）：175-183.
[18]	Richoz O， Mavrakanas N， Pajic B， et al. Corneal collagen cross-linking for ectasia after LASIK and photorefractive keratectomy： long-term results[J]. Ophthalmology，2013，120：1354-1359.
[19]	Goldich Y， Barkana Y， Wussuku LO， et al. Corneal collagen cross-linking for the treatment of progressive keratoconus： 3-year prospective outcome[J]. Can J Ophthalmol，2014，49：54-59.
[20]	Wollensak G， Iomdina E， Dittert DD， et al. Cross-linking of scleral collagen in the rabbit using riboflavin and UVA[J]. Acta ophthalmol Scand，2005，83：477-482.
[21]	Yamano T， Tsujimoto Y， Noda T， et al. Hepatotoxicity of geniposide in rats[J]. Food Chem Toxicol，1990，28：515-519.
[22]	王旻，笪琳萃，谢艳，等. 京尼平作为交联剂在天然生物材料改性中的应用[J]. 中国修复重建外科杂志，2013，27：580-585.
[23]	金勋杰，闫景龙，周磊，等. 京尼平交联明胶特性随时间变化的研究[J]. 生物医学工程学杂志，2008，25：150-153.
[24]	Sundararaghavan HG， Monteiro GA， Lapin NA， et al. Genipin-induced changes in collagen gels： correlation of mechanical properties to fluorescence[J]. J Biomed Mater Res A，2008，87：308-320.
[25]	Wang C， Lau TT， Loh WL， et al. Cytocompatibility study of a natural biomaterial crosslinker—Genipin with therapeutic model cells[J]. J Biomed Mater Res B Appl Biomater，2011， 97：58-65.
[26]	Yamazaki M， Chiba K， Mohri T， et al. Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells[J]. J Neurochem，2001，79：45-54.
[27]	Almog J， Cohen Y， Azoury M， et al. Genipin—a novel fingerprint reagent with colorimetric and fluorogenic activity[J]. J Forensic Sci，2004，49：255-257.